Buprenorphine is a potent and highly effective treatment for substance use disorder, approved for prescription in 2000. However, buprenorphine remains a controlled substance, introducing unnecessary barriers to utilization. New York must reclassify buprenorphine and ensure it is accessible to those seeking it to assist in treatment by passing S699A/A4013A.